SL20017: Infection and immunity (PA20345)
[Page last updated: 26 October 2023]
| Academic Year: | 2023/24 |
| Owning Department/School: | Department of Life Sciences |
| Credits: | 9 [equivalent to 18 CATS credits] |
| Notional Study Hours: | 180 |
| Level: | Intermediate (FHEQ level 5) |
| Period: |
|
| Assessment Summary: | ES 20%, EX 80% |
| Assessment Detail: |
|
| Supplementary Assessment: |
|
| Requisites: | |
| Learning Outcomes: |
After taking this unit, the student will be able to
* Describe the innate, adaptive and inflammatory host defence mechanisms against infectious agents * List the key features required by micro-organisms to cause human disease * Explain the role of excessive stimulation of host defence mechanisms in themselves causing human disease; * Justify the use of pharmacology of agents targeted at the exogenous infection or endogenous host defence response, * Explain the uses and limitations of antibodies in the laboratory and in the diagnosis and treatment of disease * Apply their knowledge of host defence mechanisms to interpret clinical case studies. |
| Aims: | To familiarise the students with the pathogenic mechanisms of infectious disease, the human host response to infection and the pharmacology of anti-infective agents; to describe the molecular and cellular mechanisms associated with acute and chronic inflammation, to illustrate the pathology of chronic inflammatory diseases and to introduce the pharmacology of anti-inflammatory and immunosuppressive drugs and biological agents; to illustrate clinical cases through problem-based learning. |
| Skills: | Scientific and practical skills (T/F/A)
Study skills, handling information, working with others (T/F) Problem solving (T/F) Written skills (T/F/A). |
| Content: | * The innate and adaptive immune system - antibodies, T and B lymphocytes, antigen presenting cells and the MHC, effector functions, * Mechanisms by which micro-organisms cause infectious disease. * Pharmacology of anti-infective compounds. * Mechanisms of tolerance and autoimmunity, acute and chronic inflammation, * Pharmacology of anti-inflammatory and anti-rheumatic agents and potential novel therapeutic approaches. * Use of antibodies as laboratory, diagnostic and therapeutic agents. * Problem based learning applied to relevant clinical case studies. |
| Course availability: |
SL20017 is Compulsory on the following courses:Department of Life Sciences
|
Notes:
|